Serena Fries Smith

Serena Smith, Director of Market Intelligence & Strategy – mRNA Vaccines & Therapeutics at Thermo Fisher Scientific

Content by Serena Fries Smith:

Manufacture Vaccines

Taking the mRNA Highway from Development to Commercialization

04/08/2022 | Serena Fries Smith

Driven by the success of COVID-19 vaccines, mRNA products are expanding drug developers’ pipelines.

Manufacture Bioprocessing - Upstream & Downstream

The Upstream/Downstream Process Balancing Act

03/22/2019 | Serena Fries Smith, Hunter Malanson

Early collaboration and open communication between upstream and downstream are crucial to ensure a consistent end-to-end bioprocess.

Manufacture Bioprocessing - Upstream & Downstream

Process Intensification: Getting More From Less

01/17/2019 | Serena Fries Smith

Intensifying or simplifying your bioprocess can mean more product, shorter manufacturing times, or lower costs.

Manufacture Bioprocessing - Upstream & Downstream

Keys to Consistent Bioprocessing

11/14/2018 | Serena Fries Smith

How to develop a robust and consistent bioprocess.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

Unlimited access to ALL articles
News, interviews & opinions from leading industry experts
Receive print (and PDF) copies of The Medicine Maker magazine